A groundbreaking clinical trial is testing whether specially engineered stem cells can help the brain restore its own dopamine production in people with Parkinson’s disease. Because the condition is ...
A Blue Bell startup is studying whether stabilizing mitochondria can slow progression in neurodegenerative disease.
An experimental inhibitor regrew cartilage in aged mice, opening up an alternative to arthritis and prosthetics.
Scientists at Keck Medicine of USC are testing an experimental stem cell therapy that aims to restore the brain’s ability to produce dopamine, the chemical whose loss drives Parkinson’s disease. The ...
Parkinson's disease is a progressive neurodegenerative disorder that affects more than one million people in the United States, with approximately 90,000 new cases diagnosed each year. Although ...
Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have found that a key protein can help to regenerate neural stem cells, which may improve ...
Alcohol use disorder kills more Americans than opioids or car crashes. Yet for decades, medicine ignored an FDA-approved pill that significantly reduces relapse risk and heavy-drinking days. That pill ...
Discovery from experts at Cincinnati Children's opens doors to improved stem cell transplant outcomes and potentially healthier aging CINCINNATI, Jan. 13, 2026 /PRNewswire/ -- In a groundbreaking ...
The disease affects as many as 80 million in the U.S. alone. Now Apnimed, the $400 million company behind the first ever pill to treat it, is preparing to file for FDA approval. In November 2016, ...
A Wegovy pill is now available in pharmacies nationwide. The weight loss medication is an alternative to GLP-1 injections. Below, a weight loss expert shares what you need to know. Wegovy—a medication ...
GLP-1 weight-loss pills appear to be just as effective as injections, with clinical trials showing similar average weight loss when taken correctly. The safety profile of GLP-1 pills largely mirrors ...